Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262

✍ Scribed by Monk, B.J.; Huang, H.; Penson, R.T.; Davidson, S.A.; Pearl, M.L.; O'Malley, D.M.; Bender, D.P.; Boente, M.P.; Martin, L.P.; Chan, J.K.; Walker, J.L.; McCourt, C.K.

• Book ID: 126953690
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 55 KB
• Volume: 133
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.03.159